Ellie Proussaloglou, MD
Cards
About
Research
Publications
2025
ASO Visual Abstract: Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer
Hamid S, Moses J, Lynch O, Washington R, Dicks M, Greenup R, Proussaloglou E. ASO Visual Abstract: Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer. Annals Of Surgical Oncology 2025, 33: 1246-1247. PMID: 41145938, DOI: 10.1245/s10434-025-18585-y.Peer-Reviewed Original ResearchFinancial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer
Hamid S, Moses J, Lynch O, Washington R, Dicks M, Greenup R, Proussaloglou E. Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer. Annals Of Surgical Oncology 2025, 33: 19-21. PMID: 40993463, DOI: 10.1245/s10434-025-18405-3.Commentaries, Editorials and LettersIntraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers
Gupta P, Godfrey E, Schultz K, Yu L, Bansal V, Gomez-Mayorga J, Papageorge M, Proussaloglou E, Su D, Merl M, Ward E, Sood D, Magge D, Senthil M, Kopecky K, Turaga K, Sarpel U. Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers. Annals Of Surgical Oncology 2025, 32: 8568-8572. PMID: 40877725, DOI: 10.1245/s10434-025-18051-9.Peer-Reviewed Original ResearchRacial and ethnic disparities in conversion to mastectomy following lumpectomy
Khubchandani J, KC M, Dey P, Proussaloglou E, Valero M, Berger E, Park T, Gross C, Butler P, Fayanju O, Winer E, Golshan M, Greenup R. Racial and ethnic disparities in conversion to mastectomy following lumpectomy. Breast Cancer Research And Treatment 2025, 211: 99-110. PMID: 39937397, PMCID: PMC12303253, DOI: 10.1007/s10549-025-07625-6.Peer-Reviewed Original ResearchConceptsConversion to mastectomyNeoadjuvant chemotherapyBreast conservationStage 0-III breast cancerWhite womenBreast cancerBlack womenBreast cancer careNational Cancer DatabaseMultivariate logistic regression modelEvaluate contemporary trendsLogistic regression modelsCancer careImprove disparitiesEthnic disparitiesDiagnosis yearInitial lumpectomySocio-DemographicCancer DatabaseClinical factorsMastectomyLumpectomySurgeryResultsThe studyTreatment sequence
2024
ASO Visual Abstract: National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer
Kim L, Moore M, Schneider E, Canner J, Ayyala H, Chen J, Anant P, Graetz E, Lynch M, Zanieski G, Gillego A, Valero M, Proussaloglou E, Berger E, Golshan M, Greenup R, Park T. ASO Visual Abstract: National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer. Annals Of Surgical Oncology 2024, 31: 9113-9113. DOI: 10.1245/s10434-024-16259-9.Peer-Reviewed Original ResearchNational Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer
Kim L, Moore M, Schneider E, Canner J, Ayyala H, Chen J, Anant P, Graetz E, Lynch M, Zanieski G, Gillego A, Valero M, Proussaloglou E, Berger E, Golshan M, Greenup R, Park T. National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer. Annals Of Surgical Oncology 2024, 31: 9088-9099. PMID: 39322830, DOI: 10.1245/s10434-024-16107-w.Peer-Reviewed Original ResearchHR patientsLymph nodesRate of neoadjuvant chemotherapyHospital admissionNational patterns of careEmergency departmentDecrease wound complicationsNeoadjuvant chemo-Hospital re-admissionNeoadjuvant chemotherapyIn-hospital admissionRate of reconstructionPerioperative outcomesPostoperative hematomaComplication ratePostoperative complicationsWound complicationsHome recoveryPatterns of careBreast cancerMastectomyEmergency room visitsMultivariate analysisComplicationsPatientsIncidence of Pathologic Nodal Disease in Clinically Node-Negative, Microinvasive or T1a Breast Cancers
Dey P, Kc M, Proussaloglou E, Khubchandani J, Kim L, Zanieski G, Park T, Lynch M, Gillego A, Valero M, Schneider E, Golshan M, Greenup R, Berger E. Incidence of Pathologic Nodal Disease in Clinically Node-Negative, Microinvasive or T1a Breast Cancers. Annals Of Surgical Oncology 2024, 31: 8821-8828. PMID: 39240394, DOI: 10.1245/s10434-024-16124-9.Peer-Reviewed Original ResearchTriple-negative breast cancerClinically node-negativePathologically node-negativePN+ diseaseNode-negativeBreast cancerYears of ageNodal diseaseHR-/HER2Significant comorbiditiesEpidermal growth factor receptor 2-positiveOdds of node positivityRate of nodal diseaseTriple-positive breast cancerTriple positive breast cancerEarly-stage breast cancerHR-positive/HER2-negativePathologic nodal diseasePathologic nodal positivityPredictors of pN+T1a breast cancerHR-/HER2+Sentinel node biopsyNational Cancer DatabasePathologic nodal stageLong-Term Considerations for Young Breast Cancer Patients: Fertility, Sexual Health, and Quality of Life
Proussaloglou E, Lustberg M. Long-Term Considerations for Young Breast Cancer Patients: Fertility, Sexual Health, and Quality of Life. Current Breast Cancer Reports 2024, 16: 227-236. DOI: 10.1007/s12609-024-00548-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsYoung breast cancer patientsSurvivorship careBreast cancer patientsEffectiveness of cancer careFamily planning concernsPost-partum careUnique survivorship needsQuality-of-life issuesBreast cancerQuality of lifeCancer patientsSurvivorship needsGenitourinary syndrome of menopauseCancer careDisease-free recurrenceAnti-estrogen therapyUnique group of patientsSexual healthGroup of patientsCareVaginal estrogenEndocrine therapyOverall survivalSummaryAdditional researchIatrogenic menopause
2023
The impact of converting to telehealth for cancer genetic counseling and testing during the COVID‐19 pandemic
Proussaloglou E, Koelliker E, Laprise J, Wilbur J, Robison K, Stuckey A, Crawford K. The impact of converting to telehealth for cancer genetic counseling and testing during the COVID‐19 pandemic. Journal Of Genetic Counseling 2023, 33: 834-841. PMID: 37740447, DOI: 10.1002/jgc4.1792.Peer-Reviewed Original ResearchConceptsCancer genetic counselingGC appointmentIn-person groupIn-Person VisitsIn-personGenetic counselingScreening recommendationsGenetic testingEffectiveness of telehealthAcceptance of testingLaboratory result reportingAcademic health centersElectronic medical recordsFollow-upYears of follow-upCOVID-19 pandemicHealth centersRetrospective cohort studyTH visitsInitial consultationPatients' willingnessStudy participantsMedical screeningCohort studyTelehealthUpdates in the pathology of Pregnancy Associated Breast Cancer (PABC)
Proussaloglou E, Blanco L, Siziopikou K. Updates in the pathology of Pregnancy Associated Breast Cancer (PABC). Pathology - Research And Practice 2023, 244: 154413. PMID: 36921545, DOI: 10.1016/j.prp.2023.154413.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsBreast cancerRate of lymph node involvementHigh-risk breast cancer patientsKi-67 proliferation rateSubtype of breast carcinomaPostpartum periodHormone negative tumorsLymph node involvementInvasive ductal carcinomaDevelopment of malignancyBreast cancer patientsMolecular pathwaysImmediate postpartum periodNovel treatment protocolsAssociated with tumor developmentNegative tumorsNode involvementDuctal carcinomaTumor gradeTumor sizeBreast carcinomaKi-67Prompt diagnosisImmune response mediatorsHigher Rates
Academic Achievements & Community Involvement
Clinical Care
Overview
Ellie Proussaloglou, MD, is a surgical oncologist who specializes in breast surgery.
Growing up with a mother who is a breast pathologist, Dr. Proussaloglou says she was naturally interested in medicine.
“My mother showed me that if you’re drawn to caring for women with cancer, you can do that from a variety of specialties and it sparked an interest in interdisciplinary learning,” she says. “I knew I wanted to explore aspects outside of traditional medical training. I wanted to become an expert at understanding how policy, business, and health care all intersect.”
Between college and medical school, Dr. Proussaloglou worked as a healthcare consultant for two years to further educate herself. During medical school, she continued interdisciplinary work with research on financial toxicity (how the cost of care impacts patients). She then took a unique training path focused on reproductive health.
“Most of my surgical oncology colleagues completed a general surgery residency, but I chose a residency in obstetrics and gynecology,” she says. “I wanted to better understand the spectrum of reproductive health care for women, trans and nonbinary patients, and how cancer care impacts their fertility, sexual health, and quality of life.”
When she meets a patient, Dr. Proussaloglou says the most important thing she can do is figure out “where they are.”
“Everyone comes to a new doctor's appointment with their own history, and it's impossible to get to know someone and their family fully in the course of even an hour-long visit,” she says. “I try to find out what they've heard about breast cancer. Do they have fears from seeing family members or friends who have gone through it? What is important to them? And then I walk them through their imaging, pathology, and diagnosis, and build a picture for them of what we are seeing. I try to break things down into digestible next steps.”
Dr. Proussaloglou says she tells them about the other doctors they will see, what surgery and recovery might be like, and addresses their questions and concerns.
The best part of her job, she says, is working with patients. “It's such a privilege to meet someone and to have them trust you,” she says. “Every time we go into the operating room, I love holding my patient’s hand as they go off to sleep, reminding them that we're going to take the best care of them. I wouldn't have chosen this field if I didn't really love it. And I feel so fortunate to take care of people.”
Her research focuses on patient experience and quality of life after cancer care, with a focus on young patients with breast cancer. She is also interested in caring for people who are considered high risk for developing cancer based on genetic screening.
“We all know that early detection of cancer improves outcomes and saves lives. But how can we best support individuals in making the surgical decisions that make the most sense for them and their future life,” she says.
Clinical Specialties
Fact Sheets
Breast Cancer
Learn More on Yale MedicineCancer
Learn More on Yale MedicineDiagnosing Cancer
Learn More on Yale MedicineDense Breasts
Learn More on Yale Medicine
Yale Medicine News
News & Links
Media
Meet Dr. Ellie Proussaloglou
Her joint training in breast and gynecologic surgery allows her to provide comprehensive counseling about breast cancer care, along with a thorough understanding of the gynecologic and sexual side effects of care. Her research focuses on decisions facing patients undergoing surgery or high-risk screening, with an emphasis on the financial side effects of care.
SS EOC
Smilow Shares | April 28, 2026
Hosted by: Dr. Veda Giri
Presentations by:
Amy Wiegand, MS, CGC
Ellie Proussaloglou, MD
Thejal Srikumar, MD, MPH
News
- June 30, 2026
Women’s Health Research at Yale and SWHR’s Symposium Highlights the Power of Collaboration to Advance Women’s Health Research
- March 09, 2026
Yale Cancer Center Experts Present Advances in Cancer Research at Major Surgical Meeting
- December 12, 2024
Yale Breast Surgery Launches at Lawrence + Memorial Hospital
- November 04, 2024
Smilow Cancer Genetics & Prevention Program: High-Risk Breast Cancer Clinic
Get In Touch
Contacts
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.